Evidence map›Paper›PMID 19349474›Full record

ArticleThe Journal of clinical endocrinology and metabolism2009

Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?

Christos S Mantzoros

Abstract readEditorialComment
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Leptin in human physiology and pathophysiology.American journal of physiology. Endocrinology and metabolism · 2011
    Review
  4. Repositioning leptin as a therapy for Alzheimer's disease.Therapy (London, England : 2004) · 2011
    Article
  5. Article
  6. Article
  7. Review
  8. Leptin in human physiology and therapeutics.Frontiers in neuroendocrinology · 2010
    Review
  9. Review
  10. Leptin deficiency: clinical implications and opportunities for therapeutic interventions.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2009
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Christos S Mantzoros

Funding

Role of Leptin in the Neuroendocrine Response to FastingR01DK058785 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2001 to 2011
$4.0M
The Role of Leptin in the Maintenance of a Reduced Body WeightR01DK079929 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2008 to 2012
$1.8M
Leptin and Adipokine PhysiologyK24DK081913 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2008 to 2020
$1.5M
Role of Leptin in the Neuroendocrine Response to FastingR56DK058785 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MANTZOROS, CHRISTOS S · 2005 to 2005
$85k
NIDDK NIH HHS DK58785NIDDK NIH HHS DK79929NIDDK NIH HHS DK81913NIDDK NIH HHS K24 DK081913NIDDK NIH HHS R01 DK058785NIDDK NIH HHS R01 DK079929NIDDK NIH HHS R56 DK058785
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsHumansLeptinLipodystrophyMetabolic SyndromePilot ProjectsRecombinant ProteinsTriglyceridesLeptinRecombinant ProteinsTriglycerides

Identifiers

PMID19349474
PMCPMC2730231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.